Southern Asia: Medicaments Containing Hormones Market 2024

Medicaments Containing Hormones Market Size in Southern Asia

The South Asian medicaments containing hormones market totaled $X in 2023, approximately mirroring the previous year. The total consumption indicated a resilient increase from 2012 to 2023: its value increased at an average annual rate of X% over the last eleven years. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. Based on 2023 figures, consumption decreased by X% against 2021 indices. Over the period under review, the market reached the maximum level at $X in 2016; however, from 2017 to 2023, consumption failed to regain momentum.

Medicaments Containing Hormones Production in Southern Asia

In value terms, medicaments containing hormones production totaled $X in 2023 estimated in export price. The total production indicated a prominent expansion from 2012 to 2023: its value increased at an average annual rate of X% over the last eleven years. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. Based on 2023 figures, production decreased by X% against 2021 indices. The growth pace was the most rapid in 2015 with an increase of X%. Over the period under review, production hit record highs at $X in 2016; however, from 2017 to 2023, production failed to regain momentum.

Medicaments Containing Hormones Exports

Exports in Southern Asia

In 2023, shipments abroad of medicaments containing hormones but not antibiotics increased by X% to X tons, rising for the fourth year in a row after seven years of decline. In general, exports, however, recorded a abrupt shrinkage. The most prominent rate of growth was recorded in 2022 with an increase of X% against the previous year. The volume of export peaked at X tons in 2012; however, from 2013 to 2023, the exports failed to regain momentum.

In value terms, medicaments containing hormones exports expanded notably to $X in 2023. Over the period under review, exports, however, faced a abrupt contraction. The pace of growth was the most pronounced in 2016 when exports increased by X%. Over the period under review, the exports reached the maximum at $X in 2013; however, from 2014 to 2023, the exports stood at a somewhat lower figure.

Exports by Country

In 2023, Pakistan (X tons) represented the largest exporter of medicaments containing hormones but not antibiotics in Southern Asia, generating X% of total export.

Pakistan was also the fastest-growing in terms of the medicaments containing hormones but not antibiotics exports, with a CAGR of X% from 2012 to 2023. While the share of Pakistan (X p.p.) increased significantly, the shares of the other countries remained relatively stable throughout the analyzed period.

In value terms, Pakistan ($X) also remains the largest medicaments containing hormones supplier in Southern Asia.

From 2012 to 2023, the average annual rate of growth in terms of value in Pakistan was relatively modest.

Export Prices by Country

The export price in Southern Asia stood at $X per ton in 2023, dropping by X% against the previous year. Overall, the export price recorded a deep contraction. The growth pace was the most rapid in 2013 an increase of X% against the previous year. The level of export peaked at $X per ton in 2017; however, from 2018 to 2023, the export prices remained at a lower figure.

As there is only one major export destination, the average price level is determined by prices for Pakistan.

From 2012 to 2023, the rate of growth in terms of prices for Pakistan amounted to X% per year.

Medicaments Containing Hormones Imports

Imports in Southern Asia

In 2023, the amount of medicaments containing hormones but not antibiotics imported in Southern Asia fell significantly to X tons, waning by X% compared with the year before. Over the period under review, imports continue to indicate a deep contraction. The pace of growth was the most pronounced in 2016 with an increase of X% against the previous year. As a result, imports attained the peak of X tons. From 2017 to 2023, the growth of imports failed to regain momentum.

In value terms, medicaments containing hormones imports declined notably to $X in 2023. In general, imports saw a abrupt decrease. The pace of growth was the most pronounced in 2022 with an increase of X%. Over the period under review, imports reached the peak figure at $X in 2016; however, from 2017 to 2023, imports remained at a lower figure.

Imports by Country

Afghanistan was the major importing country with an import of about X tons, which recorded X% of total imports. India (X tons) ranks second in terms of the total imports with a X% share, followed by Bangladesh (X%). Sri Lanka (X tons) took a relatively small share of total imports.

Imports into Afghanistan decreased at an average annual rate of X% from 2012 to 2023. At the same time, Bangladesh (X%) and India (X%) displayed positive paces of growth. Moreover, Bangladesh emerged as the fastest-growing importer imported in Southern Asia, with a CAGR of X% from 2012-2023. By contrast, Sri Lanka (X%) illustrated a downward trend over the same period. India (X p.p.), Afghanistan (X p.p.) and Bangladesh (X p.p.) significantly strengthened its position in terms of the total imports, while the shares of the other countries remained relatively stable throughout the analyzed period.

In value terms, India ($X) constitutes the largest market for imported medicaments containing hormones but not antibiotics in Southern Asia, comprising X% of total imports. The second position in the ranking was taken by Afghanistan ($X), with a X% share of total imports. It was followed by Bangladesh, with a X% share.

In India, medicaments containing hormones imports expanded at an average annual rate of X% over the period from 2012-2023. The remaining importing countries recorded the following average annual rates of imports growth: Afghanistan (X% per year) and Bangladesh (X% per year).

Import Prices by Country

The import price in Southern Asia stood at $X per ton in 2023, reducing by X% against the previous year. Import price indicated pronounced growth from 2012 to 2023: its price increased at an average annual rate of X% over the last eleven years. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. Based on 2023 figures, medicaments containing hormones import price increased by X% against 2020 indices. The most prominent rate of growth was recorded in 2022 an increase of X% against the previous year. Over the period under review, import prices attained the maximum at $X per ton in 2019; however, from 2020 to 2023, import prices failed to regain momentum.

There were significant differences in the average prices amongst the major importing countries. In 2023, amid the top importers, the country with the highest price was India ($X per ton), while Afghanistan ($X per ton) was amongst the lowest.

From 2012 to 2023, the most notable rate of growth in terms of prices was attained by Afghanistan (X%), while the other leaders experienced a decline in the import price figures.

Source: IndexBox Platform